14-88840883-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_144596.4(TTC8):​c.284A>G​(p.Lys95Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00454 in 1,614,074 control chromosomes in the GnomAD database, including 76 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0035 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 71 hom. )

Consequence

TTC8
NM_144596.4 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 4.99

Publications

11 publications found
Variant links:
Genes affected
TTC8 (HGNC:20087): (tetratricopeptide repeat domain 8) This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is involved in the formation of cilia. A mutation in this gene has also been implicated in nonsyndromic retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
TTC8 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa 51
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007837504).
BP6
Variant 14-88840883-A-G is Benign according to our data. Variant chr14-88840883-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 196600.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00351 (534/152316) while in subpopulation SAS AF = 0.0263 (127/4824). AF 95% confidence interval is 0.0226. There are 5 homozygotes in GnomAd4. There are 266 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC8NM_144596.4 linkc.284A>G p.Lys95Arg missense_variant Exon 4 of 15 ENST00000380656.7 NP_653197.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC8ENST00000380656.7 linkc.284A>G p.Lys95Arg missense_variant Exon 4 of 15 2 NM_144596.4 ENSP00000370031.2

Frequencies

GnomAD3 genomes
AF:
0.00352
AC:
535
AN:
152198
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0265
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00416
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00537
AC:
1349
AN:
251238
AF XY:
0.00634
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00327
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00412
Gnomad OTH exome
AF:
0.00523
GnomAD4 exome
AF:
0.00465
AC:
6799
AN:
1461758
Hom.:
71
Cov.:
32
AF XY:
0.00530
AC XY:
3855
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33474
American (AMR)
AF:
0.00351
AC:
157
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.000842
AC:
22
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0232
AC:
2000
AN:
86256
European-Finnish (FIN)
AF:
0.000580
AC:
31
AN:
53408
Middle Eastern (MID)
AF:
0.0177
AC:
102
AN:
5768
European-Non Finnish (NFE)
AF:
0.00375
AC:
4170
AN:
1111938
Other (OTH)
AF:
0.00498
AC:
301
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
390
780
1171
1561
1951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00351
AC:
534
AN:
152316
Hom.:
5
Cov.:
32
AF XY:
0.00357
AC XY:
266
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41570
American (AMR)
AF:
0.00418
AC:
64
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0263
AC:
127
AN:
4824
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10624
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00416
AC:
283
AN:
68018
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00422
Hom.:
10
Bravo
AF:
0.00300
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00453
AC:
39
ExAC
AF:
0.00592
AC:
719
Asia WGS
AF:
0.00808
AC:
28
AN:
3478
EpiCase
AF:
0.00469
EpiControl
AF:
0.00474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Bardet-Biedl syndrome 8 Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Molecular Endocrinology Laboratory, Christian Medical College
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Bardet-Biedl syndrome Uncertain:1Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 01, 2018
MAGI'S LAB - Medical Genetics Laboratory, MAGI GROUP
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTC8: BS1, BS2

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.041
T;T;.;.;T;T;.;.
Eigen
Benign
0.12
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.87
D;D;T;T;.;.;.;D
MetaRNN
Benign
0.0078
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
.;.;N;.;.;.;N;.
PhyloP100
5.0
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.0
.;.;.;.;N;N;N;N
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;.;.;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T
Vest4
0.13
ClinPred
0.043
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
gMVP
0.33
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150880478; hg19: chr14-89307227; API